SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (198)6/16/1998 11:31:00 PM
From: scaram(o)uche  Read Replies (1) of 337
 
sounds sort of relevant.......

BLOOD PRODUCTS ADVISORY COMMITTEE

DATE AND TIME: June 18 and 19, 8:00 a.m.

LOCATION: DoubleTree Hotel, Plaza I and II, 1750 Rockville Pike,
Rockville, MD.

CONTACT: Linda A. Smallwood, Ph.D., 301-827-3514.

On June 18, the committee will hear updates on hepatitis C
recipient notification and partner deferral of
xenotransplantation recipients, and discuss information provided
on the Blood Action Plan, Immune Globulin Intravenous supply
issues, and Plasma Inventory Hold. In the afternoon, the
Committee will discuss standard testing for human
immunodeficiency virus (HIV) variants.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext